Description

ATS Automation’s Life Sciences Powerhouse Moment — Radiopharma Demand Supports Visibility!

ATS Automation Tooling Systems Inc. reported fiscal 2026 results reflecting a moderate revenue increase of about 11% year-over-year, supported by solid execution across its portfolio and innovative technological solutions delivered worldwide. The company emphasized ongoing efforts to enhance profitability through margin improvement, increased free cash flow, and a higher mix of aftermarket revenue, facilitated by a recent organizational realignment focusing on core markets while repositioning or consolidating transportation-related operations. Notably, ATS is reducing involvement in large-scale automotive projects, redirecting capabilities toward specialized applications with potentially stronger returns. In the fourth quarter, revenues increased 3.2% year-over-year to $744 million, with adjusted operating earnings rising 3.4% to $76.8 million. These gains were attributed to organic growth supported by foreign exchange benefits and a higher contribution from services and spare parts.